MDT

89.34

+0.27%↑

VEEV

281.18

-0.98%↓

A

124.13

+2.21%↑

WBA

11.54

-0.09%↓

HQY

97.12

-2.5%↓

MDT

89.34

+0.27%↑

VEEV

281.18

-0.98%↓

A

124.13

+2.21%↑

WBA

11.54

-0.09%↓

HQY

97.12

-2.5%↓

MDT

89.34

+0.27%↑

VEEV

281.18

-0.98%↓

A

124.13

+2.21%↑

WBA

11.54

-0.09%↓

HQY

97.12

-2.5%↓

MDT

89.34

+0.27%↑

VEEV

281.18

-0.98%↓

A

124.13

+2.21%↑

WBA

11.54

-0.09%↓

HQY

97.12

-2.5%↓

MDT

89.34

+0.27%↑

VEEV

281.18

-0.98%↓

A

124.13

+2.21%↑

WBA

11.54

-0.09%↓

HQY

97.12

-2.5%↓

Cerus Corp

Затворен

СекторЗдравеопазване

1.55 4.73

Преглед

Промяна на цената на акция

24 ч

Текуща

Минимум

1.47

Максимум

1.55

Ключови измерители

By Trading Economics

Приходи

-5.2M

-7.7M

Продажби

-7.6M

43M

EPS

-0.04

Марж на печалбата

-17.85

Служители

614

EBITDA

-5.8M

-5.9M

Препоръки

By TipRanks

Препоръки

Купи

12-месечна прогноза

+160.4% upside

Дивиденти

By Dow Jones

Следващи печалби

31.07.2025 г.

Пазарни показатели

By TradingEconomics

Пазарна капитализация

34M

294M

Предишно отваряне

-3.18

Предишно затваряне

1.55

Настроения в новините

By Acuity

50%

50%

168 / 376 Класиране в Healthcare

Техническа оценка

By Trading Central

Увереност

Weak Bullish Evidence

Cerus Corp Графика

Миналото представяне не гарантира бъдещи резултати.

Свързани новини

10.07.2025 г., 21:42 ч. UTC

Придобивния, сливания и поглъщания

Justice Department Won't Seek Injunction for T-Mobile Acquisition of U.S. Cellular

10.07.2025 г., 17:06 ч. UTC

Придобивния, сливания и поглъщания

Portugal Begins Process to Sell Stake in National Carrier -- Update

10.07.2025 г., 17:00 ч. UTC

Значими двигатели на пазара

K Wave Media Shares Drop After Convertible Note Agreement With Anson Funds

10.07.2025 г., 16:31 ч. UTC

Придобивния, сливания и поглъщания

Blackstone Makes $664 Million Counteroffer for Warehouse REIT Amid Bidding War -- 2nd Update

10.07.2025 г., 23:47 ч. UTC

Пазарно говорене

Gold Edges Higher Amid Lingering Global Trade Tensions -- Market Talk

10.07.2025 г., 23:40 ч. UTC

Пазарно говорене

Nikkei May Trade Rangebound Amid U.S. Tariff Uncertainty -- Market Talk

10.07.2025 г., 22:36 ч. UTC

Пазарно говорене

Tourism Holdings' Profit Warning Less Concerning Than Others -- Market Talk

10.07.2025 г., 22:23 ч. UTC

Пазарно говорене

New Law Creates Winners and Losers Among Renewable-Energy Projects -- Market Talk

10.07.2025 г., 20:50 ч. UTC

Пазарно говорене
Печалби

Auto & Transport Roundup: Market Talk

10.07.2025 г., 20:50 ч. UTC

Пазарно говорене

Basic Materials Roundup: Market Talk

10.07.2025 г., 20:00 ч. UTC

Придобивния, сливания и поглъщания

Toyota Tsusho America Completes Acquisition of Radius Recycling

10.07.2025 г., 19:56 ч. UTC

Пазарно говорене

Gold Rises on Inflation Concerns -- Market Talk

10.07.2025 г., 19:33 ч. UTC

Пазарно говорене

Oil Snaps Winning Streak As Oversupply Concerns Return -- Market Talk

10.07.2025 г., 19:21 ч. UTC

Пазарно говорене

U.S. Natural Gas Rebound on Benign Storage Build -- Market Talk

10.07.2025 г., 18:46 ч. UTC

Пазарно говорене

Mexican Industrial Production Seen as Mixed in May -- Market Talk

10.07.2025 г., 18:15 ч. UTC

Пазарно говорене

Brazil's Bullish Outlook Expected to Survive Trump Tariffs -- Market Talk

10.07.2025 г., 18:03 ч. UTC

Пазарно говорене
Печалби

Travel Agency Investors Cautiously Optimistic After Delta Report -- Market Talk

10.07.2025 г., 17:57 ч. UTC

Пазарно говорене

US Labor Shortage Could Weigh on Business, Economic Growth -- Market Talk

10.07.2025 г., 17:34 ч. UTC

Печалби
Придобивния, сливания и поглъщания

Conagra Falls While Simply Good Foods Adapts. What's Eating Food Companies. -- Barrons.com

10.07.2025 г., 17:34 ч. UTC

Пазарно говорене

Canada Vows Fight Over Trump's Copper Tariffs -- Market Talk

10.07.2025 г., 17:20 ч. UTC

Пазарно говорене

Copper Climbs as Futures Wrangle With Trump Tariff -- Market Talk

10.07.2025 г., 17:20 ч. UTC

Пазарно говорене

Market Talk Roundup: Latest on U.S. Politics

10.07.2025 г., 16:20 ч. UTC

Пазарно говорене

Basic Materials Roundup: Market Talk

10.07.2025 г., 16:20 ч. UTC

Пазарно говорене

Auto & Transport Roundup: Market Talk

10.07.2025 г., 16:20 ч. UTC

Пазарно говорене

Energy & Utilities Roundup: Market Talk

10.07.2025 г., 16:02 ч. UTC

Пазарно говорене

Global Forex and Fixed Income Roundup: Market Talk

10.07.2025 г., 16:02 ч. UTC

Пазарно говорене

Global Equities Roundup: Market Talk

10.07.2025 г., 16:02 ч. UTC

Пазарно говорене

Embraer Expected to Bear Brunt of U.S. Tariffs on Brazil -- Market Talk

10.07.2025 г., 16:01 ч. UTC

Придобивния, сливания и поглъщания

Investor AB: Advanced Instruments' Acquisition of Nova Biomedical Completed

10.07.2025 г., 15:41 ч. UTC

Пазарно говорене

U.S. Natural Gas Storage Surplus Holds Steady -- Market Talk

Сравнение с други в отрасъла

Ценова промяна

Cerus Corp Прогноза

Ценова цел

By TipRanks

160.4% нагоре

12-месечна прогноза

Среден 3.88 USD  160.4%

Висок 5 USD

Нисък 1.5 USD

Според 5 анализатори от Wall Street, предложили 12-месечна ценова цел за Cerus Corp през последните три месеца.

Консенсусна оценка

By TipRanks

Купи

5 ratings

3

Купи

2

Задържане

0

Продай

Техническа оценка

By Trading Central

1.3 / 1.36Подкрепа & съпротива

Краткосрочен план

Weak Bullish Evidence

Средносрочен план

Strong Bearish Evidence

Дългосрочен план

Bearish Evidence

Настроение

By Acuity

168 / 376 Класиране в Здравеопазване

Настроения в новините

Neutral

Волатилност

Под средното

Обем новини (RCV)

Под средното

Финанси

Продажбени и админисративни разходи

Оперативни разходи

Печалба преди облагане с данъци

Продажби

Разходи за продажби

Брутна печалба от продажби

Разходи за лихви по дълг

EBITDA

Оперативна печалба

$

Относно Cerus Corp

Cerus Corporation operates as a biomedical products company. The company focuses on developing and commercializing the INTERCEPT Blood System to enhance blood safety. Its INTERCEPT Blood System, a proprietary technology for controlling biological replication that is designed to reduce blood-borne pathogens in donated blood components intended for transfusion. The company offers INTERCEPT Blood Systems for platelets and plasma, which is designed to inactivate blood-borne pathogens in platelets and plasma donated for transfusion; INTERCEPT Blood System for red blood cells to inactivate blood-borne pathogens in red blood cells donated for transfusion; and INTERCEPT Blood System for Cryoprecipitation that uses its plasma system to produce pathogen reduced cryoprecipitated fibrinogen complex for the treatment and control of bleeding, including massive hemorrhage associated with fibrinogen deficiency, as well as pathogen reduced plasma, cryoprecipitate reduced. It sells platelet and plasma systems through its direct sales force and distributors in the United States, Europe, the Commonwealth of Independent States, the Middle East, Latin America, and internationally. Cerus Corporation was incorporated in 1991 and is headquartered in Concord, California.